Form D · Biotechnology
ESO TECHNOLOGIES INC
Middleton, WI · CIK 0001438595
Offering snapshot reported Nov 5, 2009 · SEC filing
- Reported sold
- $126K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 5, 2009 | Initial | $126,000 | No comparison | 3 | SEC filing |
| Jun 24, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-119680
Source: Form D, filed Nov 5, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Gorski | Director, Executive |
| Joseph Hildebrandt | Director |
| Bonnie Reinke | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1317 Boundary Road
Middleton, WI, 53562
Middleton, WI, 53562